Small peptide formulas versus standard polymeric formulas in critically ill patients with acute gastrointestinal injury: a systematic review and meta-analysis

Sci Rep. 2023 Nov 22;13(1):20469. doi: 10.1038/s41598-023-47422-z.

Abstract

Small peptide formulas versus standard polymeric formulas for enteral nutrition in critically ill patients with acute gastrointestinal injury (AGI) have been a topic of debate. A systematic review and meta-analysis were conducted to compare their clinical and nutritional outcomes. Relevant studies from January 1980 to June 2022 were searched in PubMed, Cochrane, and Embase databases. Randomized controlled trials involving AGI grade I-IV patients were included, while children, non-AGI patients, and non-critically ill patients were excluded. Results indicated no significant difference in all-cause mortality. Patients receiving small peptide formulas showed higher daily protein intake, greater albumin growth, and higher prealbumin levels. They also had shorter lengths of stay in the intensive care unit and hospital. Conversely, patients receiving standard polymeric formulas had a higher daily calorie intake. In conclusion, the choice of formula may not affect mortality in critically ill patients with AGI. Small peptide formulas were more conducive to increase daily protein intake, decrease intensive care unit and hospital length of stay. Further large-scale randomized controlled trials evaluating the effects of these two nutritional formulas on clinical and nutritional outcomes in critically ill patients with AGI are needed to confirm these results.

Publication types

  • Meta-Analysis
  • Systematic Review

MeSH terms

  • Abdominal Injuries*
  • Child
  • Critical Illness* / therapy
  • Dietary Proteins
  • Enteral Nutrition / methods
  • Food, Formulated
  • Humans
  • Intensive Care Units
  • Peptides
  • Randomized Controlled Trials as Topic

Substances

  • Peptides
  • Dietary Proteins